Likewise, RGS7 rs2502448 was independently associated with the risk of cancer recurrence in the overall cohort (TT vs. CC/CT; aHR = 2.35; 95%CI, 1.20–4.61; P = 0.013) and among male patients (TT vs. CC/CT; aHR = 4.67; 95%CI, 2.00–10.88; P < 0.001; Table 4). The gene discussed is RGS7; the disease is cancer.